Figure 1 — DNA-methylation age and accelerated epigenetic aging in blood as a tumor marker for predicting breast cancer susceptibility

Research Paper|Volume 16, Issue 22|pp. 13534–13562

DNA-methylation age and accelerated epigenetic aging in blood as a tumor marker for predicting breast cancer susceptibility

Back to articleFigure 1(1 of 4)

100%

Figure 1.Correlation between DNAmAge/AgeAccelDiff/IEAA and chronologic age by BC status. (AgeAccelDiff, epigenetic age acceleration measured as departure of DNAmAge from chronologic age; IEAA, intrinsic epigenetic age acceleration measured as residuals by regressing DNAmAge on chronologic age, adjusted for cell composition; BC, breast cancer; DNAmAge, DNA methylation–based marker of aging). (A) DNAmAge (B) AgeAccelDiff (C) IEAA.